This proposed transplant-specific risk score offers improved performance with respect to post-transplant risk stratification in myelodysplastic syndromes.

In conclusion, this EBMT transplant-specific risk score could improve prediction of outcome for MDS patients undergoing allogeneic stem-cell transplantation.

Dec 7, 2017 · Recently, two scores were developed to predict outcome of MDS patients following allo-SCT: the transplantation risk index (TRI) by GITMO and the ...

Optimized EBMT transplant-specific risk score in myelodysplastic. Version 3. HAEMATOL/2018/200808. Haematologica. Jorge Sierra, Marie Robin, and Nicolaus ...

The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with ...

syndromes after allogeneic stem-cell transplantation. Optimized EBMT transplant-specific risk score in myelodysplastic. Version 1. HAEMATOL/2018/214452.

The aim of this study was to develop and validate a clinical and trans- plant-specific prognostic score using data from a large cohort of.

Jan 9, 2019 · The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of ...

The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with ...

The aim of this study was to develop and validate a clinical and transplant-specific prognostic score using data from a large cohort of patients with...